Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $5.06 USD
Change Today -0.15 / -2.88%
Volume 979.4K
TXMD On Other Exchanges
Symbol
Exchange
Stuttgart
NYSE Amex
As of 4:15 PM 03/6/15 All times are local (Market data is delayed by at least 15 minutes).

therapeuticsmd inc (TXMD) Snapshot

Open
$5.16
Previous Close
$5.21
Day High
$5.22
Day Low
$5.03
52 Week High
03/6/14 - $9.01
52 Week Low
05/7/14 - $3.42
Market Cap
858.6M
Average Volume 10 Days
1.2M
EPS TTM
$-0.31
Shares Outstanding
169.7M
EX-Date
06/6/08
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for THERAPEUTICSMD INC (TXMD)

Related News

No related news articles were found.

therapeuticsmd inc (TXMD) Related Businessweek News

No Related Businessweek News Found

therapeuticsmd inc (TXMD) Details

TherapeuticsMD, Inc. operates as a women’s health care product company. The company manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins and cosmetics. It offers prenatal vitamins, iron supplements, vitamin D supplements, natural menopause relief products, and cosmetic stretch mark creams under the vitaMedMD brand, as well as duplicate formulations of its prescription prenatal vitamins products under the BocaGreenMD Prena1 name. The company also focuses on conducting the clinical trials for hormone therapy pharmaceutical products that are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and vaginal dryness. TherapeuticsMD markets its products primarily through a direct national sales force to health care providers, as well as directly through its Website. The company was founded in 2008 and is headquartered in Boca Raton, Florida.

96 Employees
Last Reported Date: 11/7/14
Founded in 2008

therapeuticsmd inc (TXMD) Top Compensated Officers

Co-Founder, Chief Executive Officer and Direc...
Total Annual Compensation: $448.3K
President, Secretary and Director
Total Annual Compensation: $363.7K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $324.6K
Chief Strategy Officer and Executive Vice Pre...
Total Annual Compensation: $200.0K
Compensation as of Fiscal Year 2013.

therapeuticsmd inc (TXMD) Key Developments

TherapeuticsMD, Inc. Presents at Cowen and Company 35th Annual Healthcare Conference, Mar-04-2015 10:00 AM

TherapeuticsMD, Inc. Presents at Cowen and Company 35th Annual Healthcare Conference, Mar-04-2015 10:00 AM. Venue: The Boston Marriott Copley Place, Boston, Massachusetts, United States.

TherapeuticsMD, Inc. Presents at Stifel Healthcare Conference 2014, Nov-18-2014 08:00 AM

TherapeuticsMD, Inc. Presents at Stifel Healthcare Conference 2014, Nov-18-2014 08:00 AM. Venue: The Palace Hotel, 455 Madison Ave, New York, NY 10022, United States. Speakers: Robert G. Finizio, Co-Founder, Chief Executive Officer and Director.

TherapeuticsMD Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

TherapeuticsMD Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported net revenue increased to $4.2 million compared with $2.3 million in the prior year, reflecting an 82% increase in product sales. Operating loss was $17.8 million against $7.2 million last year. Loss before taxes was $17.8 million against $7.7 million last year. Net loss was $17.8 million or $0.12 per basic and diluted share compared with $7.7 million or $0.06 per basic and diluted share in the prior year, reflecting continued investment in two phase 3 pipeline products. Revenue growth during the quarter was primarily driven by recently launched prenatal vitamin products and continued growth of product sales in this highly competitive market. For the nine months, the company reported net revenue of $10.8 million compared with $5.9 million in the prior year. Operating loss was $37.7 million against $17.8 million last year. Loss before taxes was $37.9 million against $20.0 million last year. Net loss was $37.9 million or $0.26 per basic and diluted share compared with $20.0 million or $0.16 per basic and diluted share in the prior year. Net cash flows used in operating activities was $30.2 million against $16 million last year. Purchase of property and equipment was $0.03 million against $0.02 million last year.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TXMD:US $5.06 USD -0.15

TXMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TXMD.
View Industry Companies
 

Industry Analysis

TXMD

Industry Average

Valuation TXMD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 59.1x
Price/Book 13.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 60.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact THERAPEUTICSMD INC, please visit www.therapeuticsmd.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.